The clinical and angiographic data of 582 consecutive STEMI patients treated with PCI between 2001 and 2006 were evaluated in a retrospective study. Forty-three patients were excluded from the present study due to cardiogenic shock or rescue PCI. Patients (n=539) were categorized into the TR group (n=167) or the TF group (n=372), and several parameters were evaluated to assess the advantages and drawbacks of TR access: access-site crossover, rate of access-site complications, procedure time, fluoroscopy time, X-ray area dose, major adverse cardiac events (MACE) at 1 month, and consumption of angioplasty equipment.
In the TR group, the crossover rate to femoral access was 5 % , while in the TF group, it was 0.8 % (P<.05). There was a significant difference, in both major and minor access-site complications, between the TR group and the TF group (0 % vs. 5 % , P<.05, and 4 % vs. 9 % , P<.05, respectively). Consumption of angioplasty equipment proved to be the same for the two groups. The MACE rate was 4 % in the TR group and 11 % in the TF group (P<.05).
Our results suggest that the TR approach is a safe and effective way to treat STEMI; furthermore, site-related complications are less common with this approach.